Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Wave Life Sciences (WVE) Return on Capital Employed (2016 - 2026)

Wave Life Sciences (WVE) has disclosed Return on Capital Employed for 12 consecutive years, with 0.35% as the latest value for Q1 2026.

  • For Q1 2026, Return on Capital Employed rose 19.0% year-over-year to 0.35%; the TTM value through Mar 2026 reached 0.35%, up 19.0%, while the annual FY2025 figure was 0.54%, 1.0% up from the prior year.
  • Return on Capital Employed hit 0.35% in Q1 2026 for Wave Life Sciences, up from 0.62% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.35% in Q1 2026 and bottomed at 2.09% in Q1 2023.
  • Average Return on Capital Employed over 5 years is 1.05%, with a median of 0.95% recorded in 2022.
  • Year-over-year, Return on Capital Employed crashed -114bps in 2023 and then soared 128bps in 2024.
  • Wave Life Sciences' Return on Capital Employed stood at 1.76% in 2022, then rose by 24bps to 1.33% in 2023, then surged by 66bps to 0.45% in 2024, then crashed by -38bps to 0.62% in 2025, then skyrocketed by 44bps to 0.35% in 2026.
  • According to Business Quant data, Return on Capital Employed over the past three periods came in at 0.35%, 0.62%, and 0.84% for Q1 2026, Q4 2025, and Q3 2025 respectively.